塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/12/30 | 1,615 | 1,621 | 1,602 | 1,603 | -15 | -0.9% | 640,200 |
2010/12/29 | 1,606 | 1,622 | 1,605 | 1,618 | +9 | +0.6% | 434,500 |
2010/12/28 | 1,607 | 1,620 | 1,607 | 1,609 | -1 | -0.1% | 377,200 |
2010/12/27 | 1,600 | 1,619 | 1,600 | 1,610 | +10 | +0.6% | 510,500 |
2010/12/24 | 1,595 | 1,606 | 1,595 | 1,600 | -10 | -0.6% | 497,000 |
2010/12/22 | 1,610 | 1,615 | 1,608 | 1,610 | ±0 | ±0% | 781,700 |
2010/12/21 | 1,605 | 1,613 | 1,598 | 1,610 | +13 | +0.8% | 881,900 |
2010/12/20 | 1,601 | 1,605 | 1,592 | 1,597 | -4 | -0.2% | 932,000 |
2010/12/17 | 1,605 | 1,607 | 1,599 | 1,601 | +1 | +0.1% | 1,187,000 |
2010/12/16 | 1,602 | 1,605 | 1,594 | 1,600 | +1 | +0.1% | 875,200 |
2010/12/15 | 1,601 | 1,603 | 1,594 | 1,599 | -2 | -0.1% | 1,054,800 |
2010/12/14 | 1,588 | 1,602 | 1,584 | 1,601 | +9 | +0.6% | 890,600 |
2010/12/13 | 1,586 | 1,593 | 1,577 | 1,592 | +14 | +0.9% | 1,015,000 |
2010/12/10 | 1,603 | 1,604 | 1,558 | 1,578 | +5 | +0.3% | 4,608,300 |
2010/12/09 | 1,568 | 1,579 | 1,561 | 1,573 | -6 | -0.4% | 907,700 |
2010/12/08 | 1,550 | 1,582 | 1,547 | 1,579 | +42 | +2.7% | 2,073,700 |
2010/12/07 | 1,537 | 1,541 | 1,528 | 1,537 | -6 | -0.4% | 1,121,300 |
2010/12/06 | 1,550 | 1,553 | 1,536 | 1,543 | -10 | -0.6% | 853,500 |
2010/12/03 | 1,556 | 1,562 | 1,547 | 1,553 | +7 | +0.5% | 959,900 |
2010/12/02 | 1,564 | 1,564 | 1,539 | 1,546 | +5 | +0.3% | 1,034,000 |
2010/12/01 | 1,531 | 1,543 | 1,530 | 1,541 | +11 | +0.7% | 1,031,600 |
2010/11/30 | 1,540 | 1,556 | 1,530 | 1,530 | -23 | -1.5% | 1,352,800 |
2010/11/29 | 1,550 | 1,559 | 1,531 | 1,553 | +13 | +0.8% | 880,900 |
2010/11/26 | 1,555 | 1,563 | 1,535 | 1,540 | -20 | -1.3% | 1,454,000 |
2010/11/25 | 1,560 | 1,567 | 1,541 | 1,560 | ±0 | ±0% | 984,900 |
2010/11/24 | 1,527 | 1,570 | 1,527 | 1,560 | -7 | -0.4% | 1,518,700 |
2010/11/22 | 1,550 | 1,570 | 1,541 | 1,567 | +29 | +1.9% | 1,841,600 |
2010/11/19 | 1,513 | 1,552 | 1,510 | 1,538 | +55 | +3.7% | 3,380,300 |
2010/11/18 | 1,434 | 1,483 | 1,432 | 1,483 | +56 | +3.9% | 2,295,500 |
2010/11/17 | 1,402 | 1,432 | 1,402 | 1,427 | +17 | +1.2% | 2,142,700 |
2010/11/16 | 1,427 | 1,432 | 1,407 | 1,410 | -17 | -1.2% | 1,843,900 |
2010/11/15 | 1,430 | 1,431 | 1,412 | 1,427 | +12 | +0.8% | 1,183,000 |
2010/11/12 | 1,390 | 1,429 | 1,390 | 1,415 | +21 | +1.5% | 2,644,000 |
2010/11/11 | 1,420 | 1,420 | 1,392 | 1,394 | -25 | -1.8% | 2,498,700 |
2010/11/10 | 1,428 | 1,428 | 1,411 | 1,419 | +2 | +0.1% | 1,394,600 |
2010/11/09 | 1,401 | 1,420 | 1,397 | 1,417 | +15 | +1.1% | 2,193,800 |
2010/11/08 | 1,410 | 1,413 | 1,396 | 1,402 | -14 | -1% | 2,121,900 |
2010/11/05 | 1,432 | 1,435 | 1,413 | 1,416 | +8 | +0.6% | 1,293,400 |
2010/11/04 | 1,405 | 1,412 | 1,397 | 1,408 | +13 | +0.9% | 1,614,900 |
2010/11/02 | 1,396 | 1,401 | 1,379 | 1,395 | +4 | +0.3% | 1,236,500 |
2010/11/01 | 1,395 | 1,405 | 1,387 | 1,391 | -11 | -0.8% | 862,300 |
2010/10/29 | 1,400 | 1,409 | 1,386 | 1,402 | +2 | +0.1% | 1,724,900 |
2010/10/28 | 1,417 | 1,421 | 1,395 | 1,400 | -28 | -2% | 1,569,900 |
2010/10/27 | 1,454 | 1,455 | 1,420 | 1,428 | -17 | -1.2% | 1,617,300 |
2010/10/26 | 1,468 | 1,472 | 1,445 | 1,445 | -22 | -1.5% | 1,519,600 |
2010/10/25 | 1,483 | 1,493 | 1,467 | 1,467 | -41 | -2.7% | 1,415,600 |
2010/10/22 | 1,476 | 1,510 | 1,476 | 1,508 | +29 | +2% | 1,372,900 |
2010/10/21 | 1,504 | 1,504 | 1,475 | 1,479 | -17 | -1.1% | 1,111,700 |
2010/10/20 | 1,500 | 1,507 | 1,488 | 1,496 | -26 | -1.7% | 1,143,200 |
2010/10/19 | 1,505 | 1,529 | 1,504 | 1,522 | +19 | +1.3% | 937,000 |
3401~
3450
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 205,900円 | +5.7% | +3.9% | 2.78% | 10.24倍 | 1.35倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 895,200円 | +14.4% | +120.8% | 1.34% | 20.09倍 | 1.84倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 157,200円 | +12.2% | +180.3% | 4.71% | 56.28倍 | 1.84倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 461,900円 | +1.7% | -2.9% | 3.46% | 30.30倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 254,500円 | +11.3% | -5.4% | 2.28% | 19.59倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム